3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Conditions
Multiple Myeloma
19
Recurrence
1
Neoplasm, Residual
1
Leukemia, Plasma Cell
1
Infections
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Neoplasms
1
Cytokine Release Syndrome
1
Interventions
daratumumab
6
Dexamethasone
6
pomalidomide
4
Bortezomib
4
Focal Adhesion Protein-Tyrosine Kinases
3
venetoclax
2
Specimen Handling
2
Cyclophosphamide
2
Calcium Dobesilate
2
talquetamab
1
ixazomib
1
idecabtagene vicleucel
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
darlin protein, Dictyostelium
1
belantamab mafodotin
1
auricularum
1
X-Rays
1
Tissue Banks
1
Stem Cell Transplantation
1
Spectrometry, Fluorescence
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Pharmaceutical Preparations
1
Phantoms, Imaging
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Hyaluronoglucosaminidase
1
Biopsy
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Immunoglobulin Light-chain Amyloidosis
×
talquetamab
×
Clear all
NCT06855121
2025-03-03
NIMMS
St. Olavs Hospital
Recruiting
400 enrolled